Kangmei Pharmaceutical's Reply Notice on the Shanghai Stock Exchange's “Information Disclosure and Supervision Work Letter on the 2023 Annual Report of Kangmei Pharmaceutical Co., Ltd.”

SZSI · May 28

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.